The FY2025 (Dec) proxy of Amarin Corp Plc\uk names 16 peer companies for pay. Among Amarin Corp Plc\uk and these peers, CEO pay was 5th highest of 6 and total shareholder return was the lowest of 6.
5th highest of 6in Amarin Corp Plc\uk and its pay peers, FY2025 (Dec) by CEO pay:
$1.7M$8.5M
6th highest of 6in Amarin Corp Plc\uk and its pay peers, FY2025 (Dec) by total shareholder return:
$14$225
Pay peer group, FY2025 (Dec) proxy
| Travere Therapeutics | ||
| Evolus | ||
| Innoviva | ||
| Rigel Pharmaceuticals | ||
| Collegium Pharmaceutical | ||
| Coherus BioSciences, Inc. | Not disclosed | Not disclosed |
| Esperion Therapeutics, Inc. | Not disclosed | Not disclosed |
| Harrow | Not disclosed | Not disclosed |
| Heron Therapeutics, Inc. | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Karyopharm Therapeutics, Inc. | Not disclosed | Not disclosed |
| MacroGenics, Inc. | Not disclosed | Not disclosed |
| Puma Biotechnology, Inc. | Not disclosed | Not disclosed |
| Revance Therapeutics Inc. | Not disclosed | Not disclosed |
| Vanda Pharmaceuticals Inc. | Not disclosed | Not disclosed |
| Xeris Biopharma Holdings | Not disclosed | Not disclosed |
16 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.